Nominations open for AusBiotech and Johnson & Johnson Industry Excellence Awards

Nominations have opened for the AusBiotech and Johnson & Johnson Industry Excellence Awards, to be presented at AusBiotech 2017 in Adelaide.

The awards recognise the success stories of Australia’s biotechnology and medical technology sectors, including researchers who successfully translate their discoveries into clinical practice and companies that pioneer the developments of new treatments, devices and reliable diagnostics. According to AusBiotech CEO Glenn Cross, “The companies and individuals recognised by these awards have made a valuable contribution to the sector, driven by a passion for innovation and technical excellence in the life sciences.”

Nominations for the awards are open until 29 September in the following categories:

• Industry Leadership Award
• Australian Company of the Year
• Australian Emerging Company of the Year

Nominations must outline why the individual or company should receive the award and should not exceed 400 words. All applicants must be headquartered in Australia.

Award winners will join a distinguished group of recipients from previous years, including last year’s winners: Professor Andrew Wilks (Industry Leadership Award), Protagonist Therapeutics (Australian Company of the Year) and ResApp Health (Australian Emerging Company of the Year).

The awards will be presented on 25 October at AusBiotech 2017, which will bring together international and Australian stakeholders of the life science industry to explore current trends and insights, strengthen partnerships across the sector and advance the industry’s standing both nationally and globally.

For more information on the awards and details on how to apply, visit www.ausbiotechnc.org/program-2/industry-excellence-awards.